386 filings
Page 7 of 20
6-K
r7qmsjs
9 Jun 22
SciSparc’s Board of Directors Provides Strategic Decision
8:38am
D
ky8yx2eip3 aaxxe
8 Jun 22
$10M in equity / options, sold $10M, 1 investor
4:02pm
6-K
6o3 e9vckp
2 Jun 22
Report of Foreign Private Issuer
4:30pm
6-K
zu7zm4
1 Jun 22
SciSparc to Collaborate with Polyrizon for Brain Targeting Using Intranasal Hydrogel Systems
4:11pm
6-K
n83vyvdoj211j5aox
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
408ntt1 b92
26 May 22
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial in Tourette Syndrome
8:33am
6-K
m4pio
24 May 22
SciSparc and Clearmind Medicine Inc. Collaboration Yields Positive Results for its Psychedelic Combination Treatment
8:31am
6-K
q6gb5tv81li5
11 May 22
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields New Patent Application for Psychedelic Combination Treatment for Binge Behaviors
1:58pm
EFFECT
1hl3s0jwy
4 May 22
Notice of effectiveness
12:15am
POS AM
4a09b
28 Apr 22
Prospectus update (post-effective amendment)
5:20pm
6-K
wjb dz9blfq5p0
1 Apr 22
SciSparc Announces Closing of New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases
6:02am
6-K
gmx 89xa2empsh0tvg
17 Mar 22
SciSparc Announces Positive Results from Psychedelic-Based Pre-Clinical Trial
9:06am
6-K
ppwt8zcz 1mnu
15 Mar 22
Report of Foreign Private Issuer
7:37pm
6-K
6r3hgexksow5fs7e j6k
10 Mar 22
SciSparc Launches New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases
10:16am
6-K
gzao9ltq70cws5l82ak
9 Mar 22
SciSparc Enters Collaboration for the Development of Innovative Psychedelic-Based Pharmaceuticals
10:59am
6-K
hkkj59o
22 Feb 22
Report of Foreign Private Issuer
9:05am
6-K
59gqoaulramqm1n
17 Feb 22
Report of Foreign Private Issuer
4:00pm
6-K
ohbi7
10 Feb 22
Report of Foreign Private Issuer
4:00pm
6-K
z0d9yfga 1o854
18 Jan 22
SciSparc Advances Its Phase IIb Clinical Trial in Patients with Tourette Syndrome with its Proprietary Drug Candidate SCI-110
4:27pm